For patients with type 2 diabetes inadequately controlled on diet and exercise (± metformin), daily subcutaneous semaglutide delivered: ✅







Semaglutide vs Placebo vs Liraglutide [m89D4CUctFj]

Semaglutide vs Placebo vs Liraglutide [m89D4CUctFj]

| 1h 28m 28s | Video has closed captioning.

For patients with type 2 diabetes inadequately controlled on diet and exercise (± metformin), daily subcutaneous semaglutide delivered: ✅ Superior improvement in glycaemic control ✅ Greater weight loss …compared to liraglutide and placebo. ⚠️ Consideration: Higher rates of gastrointestinal side effects were observed with semaglutide. 💡 Clinical Insight: A powerful daily GLP-1 RA option for patients needing intensive early intervention. #DiabetesCare #Type2Diabetes #Semaglutide #Liraglutide #GlycemicControl #WeightLoss #GLP1RA #DiabetesManagement #Endocrinology #Pharmacology #MedicalResearch #ClinicalTrials #DiabetesTreatment #short #keto pills shark #new approved diet pill #dr oz best diet pill #apex diet pills side effects

Aired: January 05, 2025

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now